Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Catherine Patte

Showing results (41-50 of 82) with videos related to

Pageof 9
Sort By:
British Journal of Haematology|March 29, 2008
Excellent survival following two courses of COPAD chemotherapy in children and adolescents with resected localized B-cell non-Hodgkin's lymphoma: results of the FAB/LMB 96 international studyMary Gerrard, Mitchell S Cairo, Claire Weston, et al.
International Journal of Cancer|June 19, 2021
Childhood ovarian nonseminomatous germ cell tumors: A highly curable disease with few long-term treatment-related toxicities-Results of the French TGM95 studyRossana Pavone, Hélène Pacquement, Marlène Pasquet, et al.
Pediatric Blood & Cancer|August 24, 2013
Head and neck presentations of B-NHL and B-AL in children/adolescents: experience of the LMB89 studyCyril Lervat, Anne Auperin, Catherine Patte, et al.
European Journal of Cancer (Oxford, England : 1990)|January 15, 2018
Paediatric dysgerminoma: Results of three consecutive French germ cell tumours clinical studies (TGM-85/90/95) with late effects studyGwénaëlle Duhil de Bénazé, Hélène Pacquement, Cécile Faure-Conter, et al.
Cancer Chemotherapy and Pharmacology|December 16, 2015
International randomized phase 2 study on the addition of docetaxel to the combination of cisplatin and 5-fluorouracil in the induction treatment for nasopharyngeal carcinoma in children and adolescentsMichela Casanova, Enis Özyar, Catherine Patte, et al.
Pediatric Blood & Cancer|November 9, 2010
Cyclophosphamide monotherapy in children with Burkitt lymphoma: a study from the French-African Pediatric Oncology Group (GFAOP)Fousseyni Traoré, Carole Coze, Jean-Jacques Atteby, et al.
Blood|November 15, 2012
Outcome and pathologic classification of children and adolescents with mediastinal large B-cell lymphoma treated with FAB/LMB96 mature B-NHL therapyMary Gerrard, Ian M Waxman, Richard Sposto, et al.
BMJ Open|June 25, 2013
Parental comprehension of the benefits/risks of first-line randomised clinical trials in children with solid tumours: a two-stage cross-sectional interview studyHélène Chappuy, Naim Bouazza, Veronique Minard-Colin, et al.
Pediatric Blood & Cancer|October 5, 2023
Outcome and late effects of patients treated for childhood vaginal malignant germ cell tumorsRobin Coppin, Helene Martelli, Cyrus Chargari, et al.
Journal of Pediatric Hematology/Oncology|September 29, 2006
Mature B-cell lymphoma in children and adolescents: International group pathologist consensus correlates with histology technical qualityMark A Lones, Martine Raphael, Sherrie L Perkins, et al.
Pageof 9

Showing results (41-50 of 82) with videos related to

Sort By:
Pageof 9
British Journal of Haematology|March 29, 2008
Excellent survival following two courses of COPAD chemotherapy in children and adolescents with resected localized B-cell non-Hodgkin's lymphoma: results of the FAB/LMB 96 international studyMary Gerrard, Mitchell S Cairo, Claire Weston, et al.
International Journal of Cancer|June 19, 2021
Childhood ovarian nonseminomatous germ cell tumors: A highly curable disease with few long-term treatment-related toxicities-Results of the French TGM95 studyRossana Pavone, Hélène Pacquement, Marlène Pasquet, et al.
Pediatric Blood & Cancer|August 24, 2013
Head and neck presentations of B-NHL and B-AL in children/adolescents: experience of the LMB89 studyCyril Lervat, Anne Auperin, Catherine Patte, et al.
European Journal of Cancer (Oxford, England : 1990)|January 15, 2018
Paediatric dysgerminoma: Results of three consecutive French germ cell tumours clinical studies (TGM-85/90/95) with late effects studyGwénaëlle Duhil de Bénazé, Hélène Pacquement, Cécile Faure-Conter, et al.
Cancer Chemotherapy and Pharmacology|December 16, 2015
International randomized phase 2 study on the addition of docetaxel to the combination of cisplatin and 5-fluorouracil in the induction treatment for nasopharyngeal carcinoma in children and adolescentsMichela Casanova, Enis Özyar, Catherine Patte, et al.
Pediatric Blood & Cancer|November 9, 2010
Cyclophosphamide monotherapy in children with Burkitt lymphoma: a study from the French-African Pediatric Oncology Group (GFAOP)Fousseyni Traoré, Carole Coze, Jean-Jacques Atteby, et al.
Blood|November 15, 2012
Outcome and pathologic classification of children and adolescents with mediastinal large B-cell lymphoma treated with FAB/LMB96 mature B-NHL therapyMary Gerrard, Ian M Waxman, Richard Sposto, et al.
BMJ Open|June 25, 2013
Parental comprehension of the benefits/risks of first-line randomised clinical trials in children with solid tumours: a two-stage cross-sectional interview studyHélène Chappuy, Naim Bouazza, Veronique Minard-Colin, et al.
Pediatric Blood & Cancer|October 5, 2023
Outcome and late effects of patients treated for childhood vaginal malignant germ cell tumorsRobin Coppin, Helene Martelli, Cyrus Chargari, et al.
Journal of Pediatric Hematology/Oncology|September 29, 2006
Mature B-cell lymphoma in children and adolescents: International group pathologist consensus correlates with histology technical qualityMark A Lones, Martine Raphael, Sherrie L Perkins, et al.
Pageof 9